Lima Tânia, Gunnarsson Stefán B, Coelho Elisabete, Evtuguin Dmitry V, Correia Alexandra, Coimbra Manuel A, Cedervall Tommy, Vilanova Manuel
I3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal.
Nanomaterials (Basel). 2022 Jul 19;12(14):2475. doi: 10.3390/nano12142475.
Systemic fungal infections are associated with significant morbidity and mortality, and is the most common causative agent. Recognition of yeast cells by immune cell surface receptors can trigger phagocytosis of fungal pathogens and a pro-inflammatory response that may contribute to fungal elimination. Nevertheless, the elicited inflammatory response may be deleterious to the host by causing excessive tissue damage. We developed a nanoparticle-based approach to modulate the host deleterious inflammatory consequences of fungal infection by using β1,3-glucan-functionalized polystyrene (β-Glc-PS) nanoparticles. β-Glc-PS nanoparticles decreased the levels of the proinflammatory cytokines TNF-α, IL-6, IL-1β and IL-12p40 detected in in vitro culture supernatants of bone marrow-derived dendritic cells and macrophage challenged with cells. Moreover, β-Glc-PS nanoparticles impaired the production of reactive oxygen species by bone marrow-derived dendritic cells incubated with . This immunomodulatory effect was dependent on the nanoparticle size. Overall, β-Glc-PS nanoparticles reduced the proinflammatory response elicited by fungal cells in mononuclear phagocytes, setting the basis for a targeted therapy aimed at protecting the host by lowering the inflammatory cost of infection.
全身性真菌感染与显著的发病率和死亡率相关,并且是最常见的病原体。免疫细胞表面受体对酵母细胞的识别可触发真菌病原体的吞噬作用以及可能有助于真菌清除的促炎反应。然而,引发的炎症反应可能通过导致过度的组织损伤而对宿主有害。我们开发了一种基于纳米颗粒的方法,通过使用β1,3-葡聚糖功能化的聚苯乙烯(β-Glc-PS)纳米颗粒来调节真菌感染对宿主有害的炎症后果。β-Glc-PS纳米颗粒降低了在受到细胞挑战的骨髓来源的树突状细胞和巨噬细胞的体外培养上清液中检测到的促炎细胞因子TNF-α、IL-6、IL-1β和IL-12p40的水平。此外,β-Glc-PS纳米颗粒损害了与一起孵育的骨髓来源的树突状细胞产生活性氧的能力。这种免疫调节作用取决于纳米颗粒的大小。总体而言,β-Glc-PS纳米颗粒降低了单核吞噬细胞中真菌细胞引发的促炎反应,为旨在通过降低感染的炎症代价来保护宿主的靶向治疗奠定了基础。